{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:13:23Z","timestamp":1789784003076,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Vibrio cholerae<\/jats:italic> O1\/O139 were the predominant circulating serogroups exhibiting multi-drug resistance (MDR) during the cholera outbreak which led to cholera treatment failures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>This meta-analysis aimed to evaluate the weighted pooled resistance (WPR) rates in <jats:italic>V. cholerae<\/jats:italic> O1\/O139 isolates obtained from environmental samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We systematically searched the articles in PubMed, Scopus, and Embase (until January 2020). Subgroup analyses were then employed by publication year, geographic areas, and the quality of studies. Statistical analyses were conducted using STATA software (ver. 14.0).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 20 studies investigating 648 environmental <jats:italic>V. cholerae<\/jats:italic> O1\/O139 isolates were analysed. The majority of the studies were originated from Asia (n\u2009=\u20099). In addition, a large number of studies (n\u2009=\u200915 i.e. 71.4%) included in the meta-analysis revealed the resistance to cotrimoxazole and ciprofloxacin. The WPR rates were as follows: cotrimoxazole 59%, erythromycin 28%, tetracycline 14%, doxycycline 5%, and ciprofloxacin 0%. There was increased resistance to nalidixic acid, cotrimoxazole, furazolidone, and tetracycline while a decreased resistance to amoxicillin, ciprofloxacin, erythromycin, chloramphenicol, ampicillin, streptomycin, and ceftriaxone was observed during the years 2000\u20132020. A significant decrease in the doxycycline and ciprofloxacin-resistance rates in <jats:italic>V. cholerae<\/jats:italic> O1\/O139 isolates was reported over the years 2011\u20132020 which represents a decrease in 2001\u20132010 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Fluoroquinolones, gentamicin, ceftriaxone, doxycycline, kanamycin, and cefotaxime showed the highest effectiveness and the lowest resistance rate. However, the main interest is the rise of antimicrobial resistance in <jats:italic>V. cholerae<\/jats:italic> strains especially in low-income countries or endemic areas, and therefore, continuous surveillance, careful appropriate AST, and limitation on improper antibiotic usage are crucial.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-022-01100-3","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T05:02:58Z","timestamp":1650862978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Global status of antimicrobial resistance among environmental isolates of Vibrio cholerae O1\/O139: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"11","author":[{"given":"Xin-hui","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Zaman","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahab Hassan","family":"Kaviar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Omidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-6483","authenticated-orcid":false,"given":"Ebrahim","family":"Kouhsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"issue":"6","key":"1100_CR1","doi-asserted-by":"publisher","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","volume":"9","author":"M Ali","year":"2015","unstructured":"Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9(6):e0003832.","journal-title":"PLoS Negl Trop Dis."},{"key":"1100_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fpubh.2019.00237","volume":"7","author":"T Ramamurthy","year":"2019","unstructured":"Ramamurthy T, Mutreja A, Weill FX, Das B, Ghosh A, Nair GB. Corrigendum: revisiting the global epidemiology of cholera in conjunction with the genomics of Vibrio cholerae. Front Public Health. 2019;7:237.","journal-title":"Front Public Health"},{"issue":"13","key":"1100_CR3","doi-asserted-by":"publisher","first-page":"6226","DOI":"10.1073\/pnas.1900141116","volume":"116","author":"J Verma","year":"2019","unstructured":"Verma J, Bag S, Saha B, Kumar P, Ghosh TS, Dayal M, et al. Genomic plasticity associated with antimicrobial resistance in Vibrio cholerae. Proc Natl Acad Sci USA. 2019;116(13):6226\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"1100_CR4","doi-asserted-by":"publisher","first-page":"A83","DOI":"10.1016\/j.vaccine.2019.06.031","volume":"38","author":"B Das","year":"2020","unstructured":"Das B, Verma J, Kumar P, Ghosh A, Ramamurthy T. Antibiotic resistance in Vibrio cholerae: understanding the ecology of resistance genes and mechanisms. Vaccine. 2020;38(Suppl 1):A83\u201392.","journal-title":"Vaccine"},{"issue":"2","key":"1100_CR5","first-page":"225","volume":"133","author":"A Ghosh","year":"2011","unstructured":"Ghosh A, Ramamurthy TJTI. Antimicrobials and cholera: are we stranded? Indian J Med Res. 2011;133(2):225.","journal-title":"Indian J Med Res"},{"issue":"23","key":"1100_CR6","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1056\/NEJMoa054493","volume":"354","author":"D Saha","year":"2006","unstructured":"Saha D, Karim MM, Khan WA, Ahmed S, Salam MA, Bennish ML. Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med. 2006;354(23):2452\u201362.","journal-title":"N Engl J Med"},{"key":"1100_CR7","doi-asserted-by":"crossref","unstructured":"Yaghoubi S, Zekiy AO, Krutova M, Gholami M, Kouhsari E, Sholeh M, et al. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. 2021:1\u201320.","DOI":"10.1007\/s10096-020-04121-1"},{"issue":"11","key":"1100_CR8","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1128\/JCM.39.11.4086-4092.2001","volume":"39","author":"A Dalsgaard","year":"2001","unstructured":"Dalsgaard A, Serichantalergs O, Forslund A, Lin W, Mekalanos J, Mintz E, et al. Clinical and environmental isolates of Vibrio cholerae serogroup O141 carry the CTX phage and the genes encoding the toxin-coregulated pili. J Clin Microbiol. 2001;39(11):4086\u201392.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1100_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1128\/AEM.67.2.910-921.2001","volume":"67","author":"D Singh","year":"2001","unstructured":"Singh D, Matte MH, Matte G, Jiang S, Sabeena F, Shukla B, et al. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates. Appl Environ Microbiol. 2001;67(2):910\u201321.","journal-title":"Appl Environ Microbiol"},{"issue":"7","key":"1100_CR10","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7):e1000097.","journal-title":"PLOS Med."},{"issue":"3","key":"1100_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"key":"1100_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fpubh.2016.00231","volume":"4","author":"D Ceccarelli","year":"2016","unstructured":"Ceccarelli D, Alam M, Huq A, Colwell RR. Reduced susceptibility to extended-spectrum beta-lactams in Vibrio cholerae isolated in Bangladesh. Front Public Health. 2016;4:231.","journal-title":"Front Public Health"},{"issue":"1","key":"1100_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0035-9203(02)90233-6","volume":"96","author":"R Zachariah","year":"2002","unstructured":"Zachariah R, Harries AD, Arendt V, Nchingula D, Chimtulo F, Courteille O, et al. Characteristics of a cholera outbreak, patterns of Vibrio cholerae and antibiotic susceptibility testing in rural Malawi. Trans R Soc Trop Med Hyg. 2002;96(1):39\u201340.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1100_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1348-0421.2007.tb03924.x","volume":"51","author":"MS Islam","year":"2007","unstructured":"Islam MS, Jahid MIK, Rahman MM, Rahman MZ, Shafiqu M, Islam MSK, et al. Biofilm acts as a microenvironment for plankton-associated Vibrio cholerae in the aquatic environment of Bangladesh. Microbiology and Immunology. 2007;51:369\u201379.","journal-title":"Microbiology and Immunology"},{"key":"1100_CR15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1017\/S0950268804002705","volume":"132","author":"LC Campos","year":"2004","unstructured":"Campos LC, Zahner V, Avelar KES, Alves RM, Pereira DSG, Vital Brazil JM, et al. Genetic diversity and antibiotic resistance of clinical and environmental Vibrio cholerae suggests that many serogroups are reservoirs of resistance. Epidemiol Infect. 2004;132:985\u201392.","journal-title":"Epidemiol Infect"},{"key":"1100_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.meegid.2013.10.015","volume":"21","author":"W Gu","year":"2014","unstructured":"Gu W, Yin J, Yang J, Li C, Chen Y, Yin J, et al. Characterization of Vibrio cholerae from 1986 to 2012 in Yunnan Province, southwest China bordering Myanmar. Infect Genet Evol. 2014;21:1\u20137.","journal-title":"Infect Genet Evol"},{"issue":"1","key":"1100_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12879-019-3714-z","volume":"19","author":"D Abana","year":"2019","unstructured":"Abana D, Gyamfi E, Dogbe M, Opoku G, Opare D, Boateng G, et al. Investigating the virulence genes and antibiotic susceptibility patterns of Vibrio cholerae O1 in environmental and clinical isolates in Accra, Ghana. BMC Infect Dis. 2019;19(1):76.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"1100_CR18","doi-asserted-by":"publisher","first-page":"e0124098","DOI":"10.1371\/journal.pone.0124098","volume":"10","author":"MT Alam","year":"2015","unstructured":"Alam MT, Weppelmann TA, Longini I, De Rochars VM, Morris JG Jr, Ali A. Increased isolation frequency of toxigenic Vibrio cholerae O1 from environmental monitoring sites in Haiti. PLOS ONE. 2015;10(4):e0124098.","journal-title":"PLOS ONE"},{"issue":"3","key":"1100_CR19","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s00284-010-9802-3","volume":"62","author":"BS Li","year":"2011","unstructured":"Li BS, Tan HL, Wang DC, Deng XL, Chen JD, Zhong HJ, et al. Phenotypic and genotypic characterization Vibrio cholerae O139 of clinical and aquatic isolates in China. Curr Microbiol. 2011;62(3):950\u20135.","journal-title":"Curr Microbiol"},{"issue":"4","key":"1100_CR20","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1128\/AEM.69.4.2389-2394.2003","volume":"69","author":"R Bhanumathi","year":"2003","unstructured":"Bhanumathi R, Sabeena F, Isac SR, Shukla BN, Singh DV. Molecular characterization of Vibrio cholerae O139 bengal isolated from water and the aquatic plant Eichhornia crassipes in the River Ganga, Varanasi, India. Appl Environ Microbiol. 2003;69(4):2389\u201394.","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"1100_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1089\/fpd.2012.1310","volume":"10","author":"R Kumar","year":"2013","unstructured":"Kumar R, Lalitha KV. Prevalence and molecular characterization of Vibrio cholerae O1, non-O1 and non-O139 in tropical seafood in Cochin, India. Foodborne Pathog Dis. 2013;10(3):278\u201383.","journal-title":"Foodborne Pathog Dis"},{"key":"1100_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1099\/jmm.0.048769-0","volume":"62","author":"DE Waturangi","year":"2013","unstructured":"Waturangi DE, Wennars M, Suhartono MX, Wijaya YF. Edible ice in Jakarta, Indonesia, is contaminated with multidrug-resistant Vibrio cholerae with virulence potential. J Med Microbiol. 2013;62:352\u20139.","journal-title":"J Med Microbiol"},{"key":"1100_CR23","doi-asserted-by":"crossref","unstructured":"Al-Hilu SA, Al-Mohana AM, Jaber Z. Conventional and molecular detection of vibrio cholerae isolated from environmental water with the prevalence of antibiotic resistance mechanisms. Int J Res Pharm Sci 2019;10(3)","DOI":"10.26452\/ijrps.v10i3.1400"},{"issue":"9","key":"1100_CR24","doi-asserted-by":"publisher","first-page":"e74829","DOI":"10.1371\/journal.pone.0074829","volume":"8","author":"J Kiiru","year":"2013","unstructured":"Kiiru J, Mutreja A, Mohamed AA, Kimani RW, Mwituria J, Sanaya RO, et al. A study on the geophylogeny of clinical and environmental Vibrio cholerae in Kenya. PLOS ONE. 2013;8(9):e74829.","journal-title":"PLOS ONE"},{"key":"1100_CR25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/1471-2334-14-392","volume":"14","author":"SM Dixit","year":"2014","unstructured":"Dixit SM, Johura FT, Manandhar S, Sadique A, Rajbhandari RM, Mannan SB, et al. Cholera outbreaks (2012) in three districts of Nepal reveal clonal transmission of multi-drug resistant Vibrio cholerae O1. BMC Infect Dis. 2014;14:392.","journal-title":"BMC Infect Dis"},{"key":"1100_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1590\/S1413-86702007000100022","volume":"11","author":"JO Ibarra","year":"2007","unstructured":"Ibarra JO, Alvarado DE. Antimicrobial resistance of clinical and environmental strains of Vibrio cholerae isolated in Lima-Peru during epidemics of 1991 and 1998. Braz J Infect Dis. 2007;11:100\u20135.","journal-title":"Braz J Infect Dis"},{"key":"1100_CR27","doi-asserted-by":"crossref","unstructured":"Mercy N, Mohamed AA, Zipporah N, Chowdhury G, Pazhani GP, Ramamurthy T, et al. Phenotypic and genetic characterization of vibrio cholera o1 isolated from various regions of Kenya between 2007 and 2010. Pan Afr Med J. 2014.","DOI":"10.11604\/pamj.2014.19.8.2496"},{"issue":"1","key":"1100_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-13-366","volume":"13","author":"JFTK Akoachere","year":"2013","unstructured":"Akoachere JFTK, Masalla TN, Njom HA. Multi-drug resistant toxigenic Vibrio cholerae O1 is persistent in water sources in New Bell-Douala, Cameroon. BMC Infect Dis. 2013;13(1):1\u201312.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1100_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-14-421","volume":"14","author":"JFTK Akoachere","year":"2014","unstructured":"Akoachere JFTK, Mbuntcha CKP. Water sources as reservoirs of Vibrio cholerae O1 and non-O1 strains in Bepanda, Douala (Cameroon): Relationship between isolation and physico-chemical factors. BMC Infect Dis. 2014;14(1):1\u201310.","journal-title":"BMC Infect Dis"},{"key":"1100_CR30","unstructured":"Onyuka JHO, Kakai R, Onyango DM, Arama PF, Gichuki J, Ofulla AVO. Prevalence and antimicrobial susceptibility patterns of enteric bacteria isolated from water and fish in lake victoria basin of western kenya. 2011."},{"key":"1100_CR31","unstructured":"Eja ME, Etok CA, Asikong BE, Mboto CI, Arikpo GE. Incidence of enteric bacterial pathogens in water found at the bottom of commercial freezers in Calabar, Southeastern Nigeria. 2006."},{"issue":"3","key":"1100_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/microbiolspec.VE-0011-2014","volume":"3","author":"Z Mukandavire","year":"2015","unstructured":"Mukandavire Z, Morris JG. Modeling the Epidemiology of Cholera to Prevent Disease Transmission in Developing Countries. Microbiol Spectr. 2015;3(3):3\u201321.","journal-title":"Microbiol Spectr."},{"issue":"3","key":"1100_CR33","first-page":"279","volume":"31","author":"A Yousefi","year":"2019","unstructured":"Yousefi A, Vaez H, Sahebkar A, Khademi F. A systematic review and meta-analysis on the epidemiology of antibiotic resistance of Vibrio cholerae in Iran. Ann Ig. 2019;31(3):279\u201390.","journal-title":"Ann Ig"},{"issue":"8","key":"1100_CR34","doi-asserted-by":"publisher","first-page":"e0181496","DOI":"10.1371\/journal.pone.0181496","volume":"12","author":"LC Dengo-Baloi","year":"2017","unstructured":"Dengo-Baloi LC, Sema-Baltazar CA, Manhique LV, Chitio JE, Inguane DL, Langa JP. Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015. PLOS ONE. 2017;12(8):e0181496.","journal-title":"PLOS ONE"},{"issue":"3","key":"1100_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00018-009-0172-6","volume":"67","author":"M Thaker","year":"2010","unstructured":"Thaker M, Spanogiannopoulos P, Wright GD. The tetracycline resistome. Cell Mol Life Sci. 2010;67(3):419\u201331.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"1100_CR36","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1111\/raq.12460","volume":"12","author":"KY Loo","year":"2020","unstructured":"Loo KY, Letchumanan V, Law JWF, Pusparajah P, Goh BH, Ab Mutalib NS, et al. Incidence of antibiotic resistance in Vibrio spp. Rev Aquac. 2020;12(4):2590\u2013608.","journal-title":"Rev Aquac"},{"issue":"1","key":"1100_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-021-00985-w","volume":"10","author":"MH Ahmadi","year":"2021","unstructured":"Ahmadi MH. Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2021;10(1):1\u201312.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"5","key":"1100_CR38","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1128\/AAC.34.5.939","volume":"34","author":"SK Bhattacharya","year":"1990","unstructured":"Bhattacharya SK, Bhattacharya MK, Dutta P, Dutta D, De SP, Sikdar SN, et al. Double-blind, randomized, controlled clinical trial of norfloxacin for cholera. Antimicrob Agents Chemother. 1990;34(5):939\u201340.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1100_CR39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/jac\/37.3.575","volume":"37","author":"D Dutta","year":"1996","unstructured":"Dutta D, Bhattacharya S, Bhattacharya M, Deb A, Deb M, Manna B, et al. Efficacy of norfloxacin and doxycycline for treatment of Vibrio cholerae O139 infection. J Antimicrob Chemother. 1996;37(3):575\u201381.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1100_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1128\/AAC.42.1.206","volume":"42","author":"AK Mukhopadhyay","year":"1998","unstructured":"Mukhopadhyay AK, Basu I, Bhattacharya SK, Bhattacharya MK, Nair GB. Emergence of fluoroquinolone resistance in strains of Vibrio cholerae isolated from hospitalized patients with acute diarrhea in Calcutta, India. Antimicrob Agents Chemother. 1998;42(1):206\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1100_CR41","doi-asserted-by":"publisher","first-page":"778","DOI":"10.4102\/ajlm.v7i2.778","volume":"7","author":"Y Mohammed","year":"2018","unstructured":"Mohammed Y, Aboderin AO, Okeke IN, Olayinka AT. Antimicrobial resistance of Vibrio cholerae from sub-Saharan Africa: a systematic review. Afr J Lab Med. 2018;7(2):778.","journal-title":"Afr J Lab Med"},{"issue":"5","key":"1100_CR42","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3201\/eid2105.141233","volume":"21","author":"B Miwanda","year":"2015","unstructured":"Miwanda B, Moore S, Muyembe JJ, Nguefack-Tsague G, Kabangwa IK, Ndjakani DY, et al. Antimicrobial drug resistance of Vibrio cholerae, democratic Republic of the Congo. Emerg Infect Dis. 2015;21(5):847\u201351.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"1100_CR43","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4102\/phcfm.v12i1.2264","volume":"12","author":"SO Awuor","year":"2020","unstructured":"Awuor SO, Omwenga EO, Daud II. Geographical distribution and antibiotics susceptibility patterns of toxigenic Vibrio cholerae isolates from Kisumu County, Kenya. Afr J Prim Health Care Fam Med. 2020;12(1):e1\u20136.","journal-title":"Afr J Prim Health Care Fam Med"},{"issue":"1","key":"1100_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/fpd.2008.0127","volume":"6","author":"A Ngandjio","year":"2009","unstructured":"Ngandjio A, Tejiokem M, Wouafo M, Ndome I, Yonga M, Guenole A, et al. Antimicrobial resistance and molecular characterization of Vibrio cholerae O1 during the 2004 and 2005 outbreak of cholera in Cameroon. Foodborne Pathog Dis. 2009;6(1):49\u201356.","journal-title":"Foodborne Pathog Dis"},{"issue":"Suppl 1","key":"1100_CR45","doi-asserted-by":"publisher","first-page":"A93","DOI":"10.1016\/j.vaccine.2019.12.003","volume":"38","author":"P Chatterjee","year":"2020","unstructured":"Chatterjee P, Kanungo S, Bhattacharya SK, Dutta S. Mapping cholera outbreaks and antibiotic resistant Vibrio cholerae in India: An assessment of existing data and a scoping review of the literature. Vaccine. 2020;38(Suppl 1):A93\u2013104.","journal-title":"Vaccine"},{"key":"1100_CR46","doi-asserted-by":"crossref","unstructured":"Bagheri-Josheghani S, Bakhshi B, Mousavi M. Prevalence of antibiotic resistance in Vibrio cholerae: a meta-analysis. 2021.","DOI":"10.21203\/rs.3.rs-208720\/v1"},{"issue":"3","key":"1100_CR47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/mdr.2009.0885","volume":"15","author":"M Adabi","year":"2009","unstructured":"Adabi M, Bakhshi B, Goudarzi H, Zahraei SM, Pourshafie MR. Distribution of class I integron and sulfamethoxazole trimethoprim constin in Vibrio cholerae isolated from patients in Iran. Microb Drug Resist. 2009;15(3):179\u201384.","journal-title":"Microb Drug Resist"},{"issue":"4","key":"1100_CR48","first-page":"232","volume":"8","author":"H Masoumi-Asl","year":"2016","unstructured":"Masoumi-Asl H, Gouya MM, Rahbar M, Sabourian R. The epidemiology and antimicrobial resistance of cholera cases in Iran during 2013. Iran J Microbiol. 2016;8(4):232\u20137.","journal-title":"Iran J Microbiol"},{"key":"1100_CR49","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1089\/mdr.2017.0204","volume":"23","author":"M Aminshahidi","year":"2017","unstructured":"Aminshahidi M, Arastehfar A, Pouladfar G, Arman E, Fani F. Diarrheagenic Escherichia coli and Shigella with high rate of extended-spectrum beta-lactamase production: two predominant etiological agents of acute Diarrhea in Shiraz, Iran. Microbial Drug Resist. 2017;23:1037\u201344.","journal-title":"Microbial Drug Resist"},{"issue":"10","key":"1100_CR50","doi-asserted-by":"publisher","first-page":"e0004153","DOI":"10.1371\/journal.pntd.0004153","volume":"9","author":"A Kirpich","year":"2015","unstructured":"Kirpich A, Weppelmann TA, Yang Y, Ali A, Morris JG Jr, Longini IM. Cholera transmission in Ouest Department of Haiti: dynamic modeling and the future of the epidemic. PLOS Negl Trop Dis. 2015;9(10):e0004153.","journal-title":"PLOS Negl Trop Dis."},{"issue":"02","key":"1100_CR51","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1142\/S021833902040001X","volume":"28","author":"A Lupica","year":"2020","unstructured":"Lupica A, Gumel AB, Palumbo A. The computation of reproduction numbers for the environment-host-environment cholera transmission dynamics. J Biol Syst. 2020;28(02):183\u2013231.","journal-title":"J Biol Syst"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01100-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01100-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01100-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T06:05:57Z","timestamp":1650866757000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01100-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01100-3","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable in this section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable in this section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}